맞춤 영양 시장 규모, 점유율, 성장 및 세계 업계 분석 : 유형 및 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of personalized nutrition Market

The global personalized nutrition market was valued at USD 15.35 billion in 2025 and is projected to grow to USD 17.67 billion in 2026, reaching USD 66.95 billion by 2034, exhibiting a strong CAGR of 18.11% during the forecast period. This rapid growth reflects the increasing demand for customized dietary solutions tailored to individual health needs, genetic profiles, and lifestyle patterns.

North America dominated the market with a 35.36% share in 2025, driven by high consumer awareness, technological advancements, and the presence of leading companies. Additionally, the U.S. market is expected to reach USD 13.24 billion by 2032, highlighting strong regional demand.

Personalized nutrition involves tailoring dietary supplements and plans using data such as DNA testing, blood biomarkers, and lifestyle inputs. The growing focus on preventive healthcare and wellness is significantly boosting market expansion.

Market Trends

One of the key trends shaping the market is the rise in partnerships, mergers, and acquisitions among industry players. Companies are leveraging advanced technologies such as artificial intelligence, DNA testing, and digital health platforms to develop precise nutrition plans.

Collaborations are helping companies expand geographically and strengthen product portfolios. For instance, startups and established firms are increasingly working together to accelerate innovation and improve personalized offerings.

Another notable trend is the increasing use of data-driven nutrition solutions, enabling companies to provide highly customized recommendations based on real-time health insights.

Market Growth Drivers

1. Rising Health Awareness and Lifestyle Changes

Consumers are becoming more health-conscious, focusing on preventive healthcare and fitness. Increasing disposable income and higher spending on wellness products are driving demand for personalized supplements.

2. Increasing Investments and New Entrants

The market is witnessing a surge in startups and venture funding. Emerging companies are introducing subscription-based personalized vitamin solutions, enhancing accessibility and adoption.

3. Government Support and Awareness Programs

Governments across countries are promoting nutritional awareness and supporting industry growth through favorable policies and initiatives. Programs encouraging healthy lifestyles and supplement use are contributing to market expansion.

Restraining Factors

Despite strong growth, the market faces challenges such as:

• Data privacy concerns due to the use of personal health and genetic information
• Lack of standardized regulations across regions
• High technological complexity and operational costs

These factors may limit adoption, especially in developing markets.

Segmentation Analysis

By Form

Capsules dominate the market with a 44.65% share in 2026, owing to convenience, affordability, and easy consumption. Powder supplements are expected to grow fastest due to increasing fitness trends.

By Application

Standard supplements hold the largest share at 80.08% in 2026, driven by general wellness demand, while disease-specific supplements are gaining traction due to rising lifestyle disorders.

By Product Type

Active measurement leads with a 78.49% share in 2026, supported by digital tools, genomic kits, and AI-based recommendations offering higher accuracy.

By End-User

Adults dominate the market with a 57.67% share in 2026, driven by growing fitness awareness and demand for customized health solutions.

By Distribution Channel

Direct-to-consumer (D2C) channels are leading due to better personalization, customer engagement, and data collection capabilities.

Regional Insights

• North America: Largest market, valued at USD 5.43 billion in 2025 and USD 6.22 billion in 2026, driven by strong industry presence and innovation.
• Europe: Reached USD 4.36 billion in 2025 and USD 5.01 billion in 2026, supported by health-conscious consumers.
• Asia Pacific: Fastest-growing region, valued at USD 3.94 billion in 2025 and USD 4.58 billion in 2026, driven by rising awareness and startup activity.
• Latin America & Middle East & Africa: Emerging regions with steady growth potential due to improving health awareness.

Key Players

Major companies operating in the market include:

• Amway
• Herbalife Nutrition
• DSM SE
• Nestle Health Science
• Viome Life Sciences
• Bayer AG
• DNAFit
• Zoe Nutrition

These players are focusing on innovation, partnerships, and geographic expansion to strengthen their market position.

Conclusion

The personalized nutrition market is set for rapid and sustained growth, increasing from USD 15.35 billion in 2025 to USD 66.95 billion by 2034. The surge is driven by rising health awareness, technological advancements, and demand for customized wellness solutions. While challenges such as regulatory complexities and data privacy concerns persist, continuous innovation and investment are expected to overcome these barriers. Overall, the market presents significant opportunities for stakeholders, especially in emerging economies and digital health ecosystems, making it one of the fastest-growing segments in the global nutrition industry.

Segmentation By Form

• Tablets
• Capsules
• Powder
• Liquid
• Others

By Application

• Standard Supplements
• Disease-Based Supplements

By Product Type

• Active Measurement
• Standard Measurement

By End-User

• Adults
• Pregnant Women
• Geriatrics

By Distribution Channel

• Direct-to-Consumers
• Wellness & Fitness Centers
• Hospitals
• Others

By Region

• North America (By Form, Application, Product Type, End-user, Distribution Channel, and Country)
  • U.S. (By Form)
  • Canada (By Form)
  • Mexico (By Form)
• Europe (By Form, Application, Product Type, End-user, Distribution Channel, and Country)
  • Germany (By Form)
  • France (By Form)
  • Spain (By Form)
  • Italy (By Form)
  • U.K. (By Form)
  • Rest of Europe (By Form)
• Asia Pacific (By Form, Application, Product Type, End-user, Distribution Channel, and Country)
  • China (By Form)
  • India (By Form)
  • Japan (By Form)
  • Australia (By Form)
  • Rest of Asia Pacific (By Form)
• South America (By Form, Application, Product Type, End-user, Distribution Channel, and Country)
  • Brazil (By Form)
  • Argentina (By Form)
  • Rest of South America (By Form)
• Middle East & Africa (By Form, Application, Product Type, End-user, Distribution Channel, and Country)
  • South Africa(By Form)
  • UAE (By Form)
  • Rest of the Middle East & Africa (By Form)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Market Overview of Related/Parent Market
• 4.2. Industry SWOT Analysis
• 4.3. Recent Industry Developments - Policies, Mergers & Acquisitions, and New Product Launches
• 4.4. Supply Chain/Value Chain Analysis
• 4.5. Market Analysis and Insights (in Relation with COVID-19)

5. Global Personalized Nutrition Market Analysis, Insights and Forecast, 2026-2034

• 5.1. Key Findings / Summary
• 5.2. Market Size Estimates and Forecast
  • 5.2.1. By Form (Value)
    • 5.2.1.1. Tablets
    • 5.2.1.2. Capsules
    • 5.2.1.3. Powder
    • 5.2.1.4. Liquid
    • 5.2.1.5. Others
  • 5.2.2. By Application (Value)
    • 5.2.2.1. Standard Supplements
    • 5.2.2.2. Disease-Based Supplements
  • 5.2.3. By Product Type (Value)
    • 5.2.3.1. Active Measurement
    • 5.2.3.2. Standard Measurement
  • 5.2.4. By End-Users (Value)
    • 5.2.4.1. Adults
    • 5.2.4.2. Pregnant Women
    • 5.2.4.3. Geriatrics
  • 5.2.5. By Distribution Channel (Value)
    • 5.2.5.1. Direct-to-Consumers
    • 5.2.5.2. Wellness & Fitness Centres
    • 5.2.5.3. Hospitals
    • 5.2.5.4. Others
  • 5.2.6. By Region (Value)
    • 5.2.6.1. North America
    • 5.2.6.2. Europe
    • 5.2.6.3. Asia Pacific
    • 5.2.6.4. South America
    • 5.2.6.5. Middle East and Africa

6. North America Personalized Nutrition Market Analysis, Insights and Forecast, 2026-2034

• 6.1. Key Findings / Summary
• 6.2. Market Size Estimates and Forecast
  • 6.2.1. By Form (Value)
    • 6.2.1.1. Tablets
    • 6.2.1.2. Capsules
    • 6.2.1.3. Powder
    • 6.2.1.4. Liquid
    • 6.2.1.5. Others
  • 6.2.2. By Application (Value)
    • 6.2.2.1. Standard Supplements
    • 6.2.2.2. Disease-Based Supplements
  • 6.2.3. By Product Type (Value)
    • 6.2.3.1. Active Measurement
    • 6.2.3.2. Standard Measurement
  • 6.2.4. By End-Users (Value)
    • 6.2.4.1. Adults
    • 6.2.4.2. Pregnant Women
    • 6.2.4.3. Geriatrics
  • 6.2.5. By Distribution Channel (Value)
    • 6.2.5.1. Direct-to-Consumers
    • 6.2.5.2. Wellness & Fitness Centres
    • 6.2.5.3. Hospitals
    • 6.2.5.4. Others
  • 6.2.6. By Country
    • 6.2.6.1. U.S.
      • 6.2.6.1.1. By Form (Value)
        • 6.2.6.1.1.1. Tablets
        • 6.2.6.1.1.2. Capsules
        • 6.2.6.1.1.3. Powder
        • 6.2.6.1.1.4. Liquid
        • 6.2.6.1.1.5. Others
    • 6.2.6.2. Canada
      • 6.2.6.2.1. By Form (Value)
        • 6.2.6.2.1.1. Tablets
        • 6.2.6.2.1.2. Capsules
        • 6.2.6.2.1.3. Powder
        • 6.2.6.2.1.4. Liquid
        • 6.2.6.2.1.5. Others
    • 6.2.6.3. Mexico
      • 6.2.6.3.1. By Form (Value)
        • 6.2.6.3.1.1. Tablets
        • 6.2.6.3.1.2. Capsules
        • 6.2.6.3.1.3. Powder
        • 6.2.6.3.1.4. Liquid
        • 6.2.6.3.1.5. Others

7. Europe Personalized Nutrition Market Analysis, Insights and Forecast, 2026-2034

• 7.1. Key Findings / Summary
• 7.2. Market Size Estimates and Forecast
  • 7.2.1. By Form (Value)
    • 7.2.1.1. Tablets
    • 7.2.1.2. Capsules
    • 7.2.1.3. Powder
    • 7.2.1.4. Liquid
    • 7.2.1.5. Others
  • 7.2.2. By Application (Value)
    • 7.2.2.1. Standard Supplements
    • 7.2.2.2. Disease-Based Supplements
  • 7.2.3. By Product Type (Value)
    • 7.2.3.1. Active Measurement
    • 7.2.3.2. Standard Measurement
  • 7.2.4. By End-Users (Value)
    • 7.2.4.1. Adults
    • 7.2.4.2. Pregnant Women
    • 7.2.4.3. Geriatrics
  • 7.2.5. By Distribution Channel (Value)
    • 7.2.5.1. Direct-to-Consumers
    • 7.2.5.2. Wellness & Fitness Centres
    • 7.2.5.3. Hospitals
    • 7.2.5.4. Others
  • 7.2.6. By Country
    • 7.2.6.1. Germany
      • 7.2.6.1.1. By Form (Value)
        • 7.2.6.1.1.1. Tablets
        • 7.2.6.1.1.2. Capsules
        • 7.2.6.1.1.3. Powder
        • 7.2.6.1.1.4. Liquid
        • 7.2.6.1.1.5. Others
    • 7.2.6.2. France
      • 7.2.6.2.1. By Form (Value)
        • 7.2.6.2.1.1. Tablets
        • 7.2.6.2.1.2. Capsules
        • 7.2.6.2.1.3. Powder
        • 7.2.6.2.1.4. Liquid
        • 7.2.6.2.1.5. Others
    • 7.2.6.3. Spain
      • 7.2.6.3.1. By Form (Value)
        • 7.2.6.3.1.1. Tablets
        • 7.2.6.3.1.2. Capsules
        • 7.2.6.3.1.3. Powder
        • 7.2.6.3.1.4. Liquid
        • 7.2.6.3.1.5. Others
    • 7.2.6.4. Italy
      • 7.2.6.4.1. By Form (Value)
        • 7.2.6.4.1.1. Tablets
        • 7.2.6.4.1.2. Capsules
        • 7.2.6.4.1.3. Powder
        • 7.2.6.4.1.4. Liquid
        • 7.2.6.4.1.5. Others
    • 7.2.6.5. U.K.
      • 7.2.6.5.1. By Form (Value)
        • 7.2.6.5.1.1. Tablets
        • 7.2.6.5.1.2. Capsules
        • 7.2.6.5.1.3. Powder
        • 7.2.6.5.1.4. Liquid
        • 7.2.6.5.1.5. Others
    • 7.2.6.6. Rest of Europe
      • 7.2.6.6.1. By Form (Value)
        • 7.2.6.6.1.1. Tablets
        • 7.2.6.6.1.2. Capsules
        • 7.2.6.6.1.3. Powder
        • 7.2.6.6.1.4. Liquid
        • 7.2.6.6.1.5. Others

8. Asia Pacific Personalized Nutrition Market Analysis, Insights and Forecast, 2026-2034

• 8.1. Key Findings / Summary
  • 8.1.1. By Form (Value)
    • 8.1.1.1. Tablets
    • 8.1.1.2. Capsules
    • 8.1.1.3. Powder
    • 8.1.1.4. Liquid
    • 8.1.1.5. Others
  • 8.1.2. By Application (Value)
    • 8.1.2.1. Standard Supplements
    • 8.1.2.2. Disease-Based Supplements
  • 8.1.3. By Product Type (Value)
    • 8.1.3.1. Active Measurement
    • 8.1.3.2. Standard Measurement
  • 8.1.4. By End-Users (Value)
    • 8.1.4.1. Adults
    • 8.1.4.2. Pregnant Women
    • 8.1.4.3. Geriatrics
  • 8.1.5. By Distribution Channel (Value)
    • 8.1.5.1. Direct-to-Consumers
    • 8.1.5.2. Wellness & Fitness Centres
    • 8.1.5.3. Hospitals
    • 8.1.5.4. Others
  • 8.1.6. By Country
    • 8.1.6.1. China
      • 8.1.6.1.1. By Form (Value)
        • 8.1.6.1.1.1. Tablets
        • 8.1.6.1.1.2. Capsules
        • 8.1.6.1.1.3. Powder
        • 8.1.6.1.1.4. Liquid
        • 8.1.6.1.1.5. Others
    • 8.1.6.2. India
      • 8.1.6.2.1. By Form (Value)
        • 8.1.6.2.1.1. Tablets
        • 8.1.6.2.1.2. Capsules
        • 8.1.6.2.1.3. Powder
        • 8.1.6.2.1.4. Liquid
        • 8.1.6.2.1.5. Others
    • 8.1.6.3. Japan
      • 8.1.6.3.1. By Form (Value)
        • 8.1.6.3.1.1. Tablets
        • 8.1.6.3.1.2. Capsules
        • 8.1.6.3.1.3. Powder
        • 8.1.6.3.1.4. Liquid
        • 8.1.6.3.1.5. Others
    • 8.1.6.4. Australia
      • 8.1.6.4.1. By Form (Value)
        • 8.1.6.4.1.1. Tablets
        • 8.1.6.4.1.2. Capsules
        • 8.1.6.4.1.3. Powder
        • 8.1.6.4.1.4. Liquid
        • 8.1.6.4.1.5. Others
    • 8.1.6.5. Rest of Asia Pacific
      • 8.1.6.5.1. By Form (Value)
        • 8.1.6.5.1.1. Tablets
        • 8.1.6.5.1.2. Capsules
        • 8.1.6.5.1.3. Powder
        • 8.1.6.5.1.4. Liquid
        • 8.1.6.5.1.5. Others

9. South America Personalized Nutrition Market Analysis, Insights and Forecast, 2026-2034

• 9.1. Key Findings / Summary
  • 9.1.1. By Form (Value)
    • 9.1.1.1. Tablets
    • 9.1.1.2. Capsules
    • 9.1.1.3. Powder
    • 9.1.1.4. Liquid
    • 9.1.1.5. Others
  • 9.1.2. By Application (Value)
    • 9.1.2.1. Standard Supplements
    • 9.1.2.2. Disease-Based Supplements
  • 9.1.3. By Product Type (Value)
    • 9.1.3.1. Active Measurement
    • 9.1.3.2. Standard Measurement
  • 9.1.4. By End-Users (Value)
    • 9.1.4.1. Adults
    • 9.1.4.2. Pregnant Women
    • 9.1.4.3. Geriatrics
  • 9.1.5. By Distribution Channel (Value)
    • 9.1.5.1. Direct-to-Consumers
    • 9.1.5.2. Wellness & Fitness Centres
    • 9.1.5.3. Hospitals
    • 9.1.5.4. Others
  • 9.1.6. By Country
    • 9.1.6.1. Brazil
      • 9.1.6.1.1. By Form (Value)
        • 9.1.6.1.1.1. Tablets
        • 9.1.6.1.1.2. Capsules
        • 9.1.6.1.1.3. Powder
        • 9.1.6.1.1.4. Liquid
        • 9.1.6.1.1.5. Others
    • 9.1.6.2. Argentina
      • 9.1.6.2.1. By Form (Value)
        • 9.1.6.2.1.1. Tablets
        • 9.1.6.2.1.2. Capsules
        • 9.1.6.2.1.3. Powder
        • 9.1.6.2.1.4. Liquid
        • 9.1.6.2.1.5. Others
    • 9.1.6.3. Rest of South America
      • 9.1.6.3.1. By Form (Value)
        • 9.1.6.3.1.1. Tablets
        • 9.1.6.3.1.2. Capsules
        • 9.1.6.3.1.3. Powder
        • 9.1.6.3.1.4. Liquid
        • 9.1.6.3.1.5. Others

10. Middle East & Africa Personalized Nutrition Market Analysis, Insights and Forecast, 2026-2034

• 10.1. Key Findings / Summary
  • 10.1.1. By Form (Value)
    • 10.1.1.1. Tablets
    • 10.1.1.2. Capsules
    • 10.1.1.3. Powder
    • 10.1.1.4. Liquid
    • 10.1.1.5. Others
  • 10.1.2. By Application (Value)
    • 10.1.2.1. Standard Supplements
    • 10.1.2.2. Disease-Based Supplements
  • 10.1.3. By Product Type (Value)
    • 10.1.3.1. Active Measurement
    • 10.1.3.2. Standard Measurement
  • 10.1.4. By End-Users (Value)
    • 10.1.4.1. Adults
    • 10.1.4.2. Pregnant Women
    • 10.1.4.3. Geriatrics
  • 10.1.5. By Distribution Channel (Value)
    • 10.1.5.1. Direct-to-Consumers
    • 10.1.5.2. Wellness & Fitness Centres
    • 10.1.5.3. Hospitals
    • 10.1.5.4. Others
  • 10.1.6. By Country
    • 10.1.6.1. UAE
      • 10.1.6.1.1. By Form (Value)
        • 10.1.6.1.1.1. Tablets
        • 10.1.6.1.1.2. Capsules
        • 10.1.6.1.1.3. Powder
        • 10.1.6.1.1.4. Liquid
        • 10.1.6.1.1.5. Others
    • 10.1.6.2. South Africa
      • 10.1.6.2.1. By Form (Value)
        • 10.1.6.2.1.1. Tablets
        • 10.1.6.2.1.2. Capsules
        • 10.1.6.2.1.3. Powder
        • 10.1.6.2.1.4. Liquid
        • 10.1.6.2.1.5. Others
    • 10.1.6.3. Rest of Middle East & Africa
      • 10.1.6.3.1. By Form (Value)
        • 10.1.6.3.1.1. Tablets
        • 10.1.6.3.1.2. Capsules
        • 10.1.6.3.1.3. Powder
        • 10.1.6.3.1.4. Liquid
        • 10.1.6.3.1.5. Others

11. Competitive Matrix

• 11.1. Business Strategies Adopted by Leading Players
• 11.2. Global Personalized Nutrition Market Revenue Share/Ranking Analysis, By Key Manufacturer, 2025

12. Company Profiles

• 12.1. Amway
  • 12.1.1. Overview
  • 12.1.2. Description
  • 12.1.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.1.4. Recent Developments
• 12.2. Herbalife International of America, Inc.
  • 12.2.1. Overview
  • 12.2.2. Description
  • 12.2.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.2.4. Recent Developments
• 12.3. DSM SE
  • 12.3.1. Overview
  • 12.3.2. Description
  • 12.3.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.3.4. Recent Developments
• 12.4. Metagenics
  • 12.4.1. Overview
  • 12.4.2. Description
  • 12.4.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.4.4. Recent Developments
• 12.5. Nestle Health Science
  • 12.5.1. Overview
  • 12.5.2. Description
  • 12.5.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.5.4. Recent Developments
• 12.6. Viome Life Sciences, Inc.
  • 12.6.1. Overview
  • 12.6.2. Description
  • 12.6.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.6.4. Recent Developments
• 12.7. Bayer AG
  • 12.7.1. Overview
  • 12.7.2. Description
  • 12.7.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.7.4. Recent Developments
• 12.8. Harbin Pharmaceutical Group Co., Ltd (GNC Holndings Inc.,)
  • 12.8.1. Overview
  • 12.8.2. Description
  • 12.8.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.8.4. Recent Developments
• 12.9. DNAFit
  • 12.9.1. Overview
  • 12.9.2. Description
  • 12.9.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.9.4. Recent Developments
• 12.10. Zoe Nutrition Private Limited.
  • 12.10.1. Overview
  • 12.10.2. Description
  • 12.10.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.10.4. Recent Developments

13. Strategic Recommendations